ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » West Virginia » Rheumatology

Top Rheumatology Prescribers in West Virginia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
WASSIM SAIKALI MD

Rheumatology

11,737

$1.5M

1123
702 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

26%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$128
Average prescription price

Avg: $164

WILLIAM DENNISON MD

Rheumatology

11,680

$973K

697
546 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

19%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$83
Average prescription price

Avg: $164

ROBERT VAWTER MD

Rheumatology

8,023

$1.24M

697
583 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$154
Average prescription price

Avg: $164

THOMAS HOWARD MD

Rheumatology

6,434

$1.46M

490
318 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

22%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$226
Average prescription price

Avg: $164

SHELLY KAFKA M.D.

Rheumatology

5,484

$711K

633
427 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$130
Average prescription price

Avg: $164

MICHAEL ISTFAN MD

Rheumatology

5,252

$617K

528
334 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$118
Average prescription price

Avg: $164

GURPREET BRAR MD

Rheumatology

4,904

$1.17M

529
416 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$240
Average prescription price

Avg: $164

BRIAN HOUSTON MD

Rheumatology

4,494

$1.05M

375
292 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

26%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$234
Average prescription price

Avg: $164

LEAH TRIPLETT D.O.

Rheumatology

3,834

$634K

377
236 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 25%

$165
Average prescription price

Avg: $164

SUZANNE GHARIB MD

Rheumatology

2,425

$549K

265
169 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$227
Average prescription price

Avg: $164

COLLEEN WATKINS M. D.

Rheumatology

1,960

$479K

225
138 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$244
Average prescription price

Avg: $164

RALPH WEBB MD

Rheumatology

1,318

$360K

121
70 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$273
Average prescription price

Avg: $164

JAMES BRICK M. D.

Rheumatology

1,303

$299K

137
80 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$229
Average prescription price

Avg: $164

ADENRELE OLAJIDE M.D.07

Rheumatology

1,162

$265K

162
93 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$228
Average prescription price

Avg: $164

YVONNE HOOGLAND MD

Rheumatology

1,146

$223K

114
80 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$195
Average prescription price

Avg: $164

JO ANN HORNSBY M. D.

Rheumatology

634

$237K

138
91 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 25%

$374
Average prescription price

Avg: $164

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank